Development and evaluation of clinically effective “ <i>APOE</i> Genotyping SNP Array System” for ARIA risk assessment in Alzheimer's Disease patients
It was demonstrated that the APOE Genotyping SNP Array is a valuable tool for assessing the risk of ARIA in patients receiving anti-Aβ antibody drugs. In the future, it is anticipated that the test will be widely utilized to evaluate the risk of ARIA prior to the administration of anti-Aβ antibody drugs.
Authors
- Masahiro Ieko (ORCID: https://orcid.org/0000-0003-1854-4543)
- Osamu Shibata
- Kazuya Kurachi
- Nozomu Watanabe
- Shoji Okajima
- Jeffrey Albrecht
Institutions
- Sapporo University (JP)
- United States Gypsum (United States) (US)
- Chuo University (JP)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102590
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00